Doward, Lynda
Svedsater, Henrik
Whalley, Diane
Crawford, Rebecca
Leather, David
Lay-Flurrie, James
Bosanquet, Nick
Funding for this research was provided by:
GlaxoSmithKline foundation (204500, 204500, 204500, 204500, 204500, 204500, 204500)
Article History
Received: 25 July 2018
Accepted: 8 July 2019
First Online: 15 August 2019
Competing interests
: L.D., D.W. and R.C. are employees of RTI Health Solutions, which has received funding from GlaxoSmithKline plc. H.S., D.L. and J.L.-F. are GlaxoSmithKline plc. employees and hold GlaxoSmithKline plc. shares. N.B. was a chief investigator for the SLS follow-up interviews and received a fee from GlaxoSmithKline plc.